COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...
April 21 () - Moderna said on Tuesday the European Commission had granted marketing authorization for a combination ...
The European Medicines Agency’s (EMA) drug review committee has taken a positive stance on granting marketing authorisation to Moderna’s combination Covid-19 and influenza vaccine, mCombriax ...
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...
The updated mRNA vaccines target the LP.8.1 variant of SARS-CoV-2. The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and ...
Moderna said it's planning to submit a request to the U.S. Food and Drug Administration to authorize a low-dose COVID-19 vaccine for children under 6 years old, part of a push to inoculate the 18 ...
Americans may face the next respiratory disease season without clear guidance for COVID shots and updated flu vaccines after ...
CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results